Microgestin Fe 1/20 Kit
Product Images NDC 51862-866

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Microgestin Fe 1/20 (NDC 51862-866). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mayne Pharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Image 01)

Chemical structure diagrams of the active ingredients Norethindrone Acetate and Ethinyl Estradiol shown side by side. Each structure depicts the molecular framework of these steroid hormones, including their characteristic ring systems and functional groups.*

FDA Label Image

2 (Image 02)

A data table titled 'Lowest Expected and Typical Failure Rates During the First Year of Continuous Use of a Method' showing the percentage of women experiencing unintended pregnancy for various contraceptive methods. It lists methods including oral contraceptives, diaphragm, spermicides, vaginal sponge, implants, injections, IUD, condoms, cervical cap, periodic abstinence, withdrawal, and sterilization, with columns for lowest expected and typical failure rates.*

FDA Label Image

3 (Image 03)

A boxed warning text panel highlighting the increased risk of serious cardiovascular side effects from oral contraceptive use associated with cigarette smoking. It emphasizes that the risk is higher with age and heavy smoking (15 or more cigarettes per day), particularly in women over 35 years old, and advises women using oral contraceptives not to smoke.*

FDA Label Image

4 (Image 04)

A bar chart titled 'Circulatory Disease Mortality Rates per 100,000 Woman Years by Age, Smoking Status and Oral Contraceptive Use.' The chart compares mortality rates among ever-users (non-smokers and smokers) and controls (non-smokers and smokers) across four age groups: 15-24, 25-34, 35-44, and 45+. Mortality rates increase significantly with age, especially for smokers who are ever-users of oral contraceptives.*

FDA Label Image

5 (Image 05)

A data table showing the annual number of birth-related or method-related deaths associated with control of fertility per 100,000 nonsterile women by fertility control method according to age groups 15-19, 20-24, 25-29, 30-34, 35-39, and 40-44. Methods include no fertility control, oral contraceptives (smoker and non-smoker), IUD, condom, diaphragm/spermicide, and periodic abstinence, with footnotes indicating which deaths are birth related and which are method related.*

FDA Label Image

6 (Image 06)

Warning text panel highlighting the increased risk of serious cardiovascular side effects from oral contraceptive use associated with cigarette smoking, especially in women over 35 years old and heavy smokers (15 or more cigarettes per day). It advises women who use oral contraceptives not to smoke.*

FDA Label Image

7 (Image 07)

An instructional diagram showing a hand placing a day label sticker on a Microgestin Fe 1/20 oral contraceptive pill pack. The image explains how to start taking the pills using a Sunday or Day 1 starter, highlighting the order of pill intake from left to right each week and distinguishing between pale yellow active pills and a brown inactive pill.*

FDA Label Image

8 (Image 08)

Text panel warning that cigarette smoking increases the risk of serious cardiovascular side effects from oral contraceptive use, especially in women over 35 years old and heavy smokers (15 or more cigarettes per day). It advises women who use oral contraceptives strongly not to smoke.*

FDA Label Image

9 (Image 09)

A warning panel about cigarette smoking and oral contraceptive use, advising that smoking increases the risk of serious cardiovascular side effects from oral contraceptive use, especially in women over 35 and those who smoke heavily (15 or more cigarettes per day), and strongly advises women who use oral contraceptives not to smoke.*

FDA Label Image

10 (Image 10)

A data table showing the annual number of birth-related or method-related deaths associated with fertility control per 100,000 nonsterile women by fertility control method and age group. The table lists methods including no fertility control, oral contraceptives (smoker and non-smoker), IUD, condom, diaphragm/spermicide, and periodic abstinence, with death rates specified across age groups 15-19, 20-24, 25-29, 30-34, 35-39, and 40-44 years.*

FDA Label Image

11 (Image 11)

Illustration showing how to start using the Microgestin Fe 1/20 oral contraceptive pill kit. It depicts a hand placing a day label sticker on the kit's blister pack to align the first pill with the user's starting day of the week, with instructions to take pills from left to right each week. The blister pack contains three pale yellow active pills and one brown inactive pill per row, demonstrating both Sunday and Day 1 starter options.*

FDA Label Image

12 (Image 12)

FDA Label Image

13 (Image 13)

Packaging label for Microgestin Fe 1/20 kit containing Norethindrone Acetate and Ethinyl Estradiol Tablets, USP and Ferrous Fumarate Tablets. The label shows the product name, active ingredients, dosage form as kit, manufacturer Mayne Pharma Inc., and NDC 51862-866. It specifies 6 blister cards of 28 tablets each including 21 pale yellow and 7 brown tablets. Additional regulatory and storage information is included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.